Novavax, Inc. (NVAX)
NVAX price $10.57 -0.44 -4.03%
- Ticker
- NVAX
- Price
- $10.57
- Change
- -0.44 -4.03%
- Market cap
- $1.74B
- P/E
- -7.52
- Forward P/E
- 402.61
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 50
Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal…